[中文簡歷 Chinese CV]                   [英文簡歷 English CV]

Professor Wei-Chiao Chang


Director of Clinical Pharmacogenomics and Pharmacoproteomics Msc program, Taipei Medical University, Taiwan
Professor in the Department of Clinical Pharmacy, Taipei Medical University, Taiwan
Professor in the Graduate Institute of Clinical Medicine, Kaohsiung Medical University, Taiwan
The Secretary-General of The Pharmaceutical Society of Taiwan

Specialty:

Immune repertoire, Immunopharmacogenomics, Calcium Signalling

       photo_wcc

Academic Qualifications
1. D.Phil. Department of Physiology, Anatomy and Genetics, University of Oxford, UK
2. MSc, Department of Pharmacology, National Cheng-Kung University, Taiwan
3. BSc, Department of Pharmacy, Taipei Medical University, Taiwan


Previous Career History
1. Associate Professor in the Department of Clinical Pharmacy, Taipei Medical University, Taiwan
2. Assistant Professor in the Department of Medical Genetics, Kaohsiung Medical University, Taiwan
3. Division Director of the Department of Research and Development, Kaohsiung Medical University, Taiwan (Genomics core )
4. International Special Research Scientist in Prof. Yusuke Nakamura’s lab at Genomic Medicine Research Center, RIKEN, Japan
5. Visiting Scholar in the Center for Advanced Biomedical Science, Waseba University, Japan
6. Junior Medical Specialist in the Department of Health, Taiwan


Selected Publications

  • STIM1 Overexpression Promotes Colorectal Cancer Progression, Cell Motility and COX-2 Expression.
    Wang JY, Sun J, Huang MY, Wang YS, Hou MF, Sun Y, He H, Krish-na N, Chiu SJ, Lin S, Yang S*, Chang WC*.
    Oncogene. 2015 ;34, 4358–4367.(published online 10 November 2014)
  • STIM1- and Orai1-mediated Ca(2+) oscillation orchestrates invadopodium formation and melanoma invasion.
    Sun J, Lu F, He H, Shen J, Messina J, Mathew R, Wang D, Sarnaik AA, Chang WC, Kim M, Cheng H, Yang S.
    J Cell Biol. 2014 Nov 24;207(4):535-48.[Epub 2014 Nov 17]
  • Involvement of Intracellular Calcium Mobilization in IL-8 Activation in Human Retinal Pigment Epithelial Cells.
    Yang IH, Wong JH, Chang CM, Chen BK, Tsai YT, Chen WC, Wang ET, Hsu WL, Chang WC
    Invest Ophthalmol Vis Sci. 2015 Jan 15;56(2):761-9.
  • PTX3 gene activation in EGF-induced head and neck cancer cell metastasis.
    Chang WC, Wu SL, Huang WC, Hsu JY, Chan SH, Wang JM, Tsai JP, Chen BK.
    Oncotarget. 2015 Apr 10;6(10):7741-57.
  • Translocation of NF-κB and expression of cyclooxygenase-2 are enhanced by ketamine-induced ulcerative cystitis in rat bladder.
    Juan YS, Lee YL, Long CY, Wong JH, Jang MY, Lu JH, Wu WJ, Huang YS, Chang WC, Chuang SM.
    Am J Pathol. 2015 Aug;185(8):2269-85.
  • Correlation of clinical features and genetic profiles of stromal interaction molecule 1 (STIM1) in colorectal cancers.
    Wong HS, Chang WC.
    Oncotarget. 2015 Dec 8;6(39):42169-82.
  • Integrative bioinformatic analyses of an oncogenomic profile reveal the biology of endometrial cancer and guide drug discovery.
    Wong HS, Juan YS, Wu MS, Zhang YF, Hsu YW, Chen HH, Liu WM, Chang WC.
    Oncotarget. 2016 Feb 2;7(5):5909-23.
  • Characterization of cytokinome landscape for clinical responses in human cancers.
    Wong HS, Chang CM, Liu X, Huang WC, Chang WC.
    Oncoimmunology. 2016 Nov 4;5(11):e1214789.
  • Prediction for Intravenous Immunoglobulin Resistance by Using Weighted Genetic Risk Score Identified From Genome-Wide Association Study in Kawasaki Disease.
    Ho-Chang Kuo, Henry Sung-Ching Wong, Wei-Pin Chang, Ben-Kuen Chen, Mei-Shin Wu, Kuender D. Yang, Kai-Sheng Hsieh, Yu-Wen Hsu, Shih-Feng Liu, Xiao Liu,Chang WC.
    Circulation.Cardiovascular genetics. 2017 Oct 1(5). pii: e001625.
  • Losses of cytokines and chemokines are common genetic features of human cancers: the somatic copy number alterations are correlated with patient prognoses and therapeutic resistance.
    Wong HS,Chang WC.
    Oncoimmunology.2018 Jul 30.(7):e1468951
  •  

     

    Contact us

      Telephone:
      02-2736-1661 #6188


      Director Email:
      wcc@tmu.edu.tw photo_wcc